25th-May-2012 08:19Source: NSE

Shasun Pharmaceuticals Limited

Shasun Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 24, 2012 has recommended a final dividend of 20% (Rs. 0.40ps per share) o...

24th-May-2012 20:18Source: BSE

Shasun Pharma- Results Press Release

Shasun Pharmaceuticals Ltd has informed BSE regarding a Press Release titled, "Shasun achieved Sales of Rs 1066 Crores and PAT of Rs 101 Crores in FY 12 Consolidated-substantial improvement."

24th-May-2012 19:23Source: NSE

SHASUN PHARMACEUTICALS LIMITED Press Release

Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 24, 2012, titled "Shasun announces Year ended 31st March 12 Results: Shasun achieved sales of Rs 1066 Crore...

24th-May-2012 18:40Source: NSE

SHASUN PHARMACEUTICALS LIMITED Financial Result Updates

Shasun Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2012.

24th-May-2012 17:46Source: BSE

Shasun Pharma- Board recommends Final Dividend

Shasun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2012, inter alia, has recommended a final dividend of 20% (Rs. 0.40ps per share) o...

24th-May-2012 17:29Source: BSE

Shasun Pharma- Financial Results for March 31, 2012

Shasun Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended March 31, 2012.

17th-May-2012 12:01Source: BSE

Shasun Pharma- Board to consider Dividend

Shasun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2012, to consider the Audited Financial Results and to consider recommendati...

24th-Apr-2012 17:11Source: BSE

Shasun Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Shasun Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

24th-Apr-2012 15:18Source: BSE

Shasun Pharma- Disclosures under Reg.13(4),13(4A)and13(6) of SEBI (Prohibition of Insider Trading) Regulations,1992

Lifecell International Pvt Ltd has submitted the disclosures under Reg.13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

23rd-Apr-2012 17:30Source: BSE

Shasun Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Shasun Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992